Withdrawn application: Amyvid, 26/02/2025

Annex V - List of hydroxyethyl starch (HES)-containing medicinal products in the European Union

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

EMA closed 29-30 May

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised

Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)

Start of procedure: Type II variation - extension of indication (26 April - 22 May 2025)

Minutes of the CHMP meeting 9-12 December 2024